Clearance Summary
Keikku Electronic stethoscope received FDA 510(k) clearance under submission number K233313, sponsored by Lapsi Health Holding B.V.. The device was reviewed via the Traditional premarket notification pathway and assigned to the Cardiovascular review panel. The statutory decision date of record is 2024-04-10.
- Submission: K233313
- Applicant / Sponsor: Lapsi Health Holding B.V.
- Clearance pathway: Traditional
- Review panel: Cardiovascular
- Device class: Class II
- Regulation citation: 21 CFR 870.1875
- Decision date: 2024-04-10
Classification & Regulation
This clearance is catalogued under FDA product code DQD and 21 CFR 870.1875, within the Cardiovascular review panel as a Class II device.